Boehringer Ingelheim Pharma GmbH & Co. KG has synthesized NADPH oxidase 4 (NOX4) inhibitors reported to be useful for the treatment of atherosclerosis, cancer, pulmonary hypertension, inflammatory ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The drugmaker has settled a series of lawsuits related to Zantac over the past 12 months, including several in California.

In a joint report published on Monday, analysts estimated the market for obesity treatments could expand to $200 billion by ...

The report is based on insights from multiple interviews of global lifesciences leaders about their GenAI journey, primary ...

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results GlobeNewswire September 05, 2024 Ingelheim, Germany and Basel ...

INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address ...

INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic ...

Boehringer Ingelheim, a biopharmaceutical company involved in both human and animal health, has acquired Saiba Animal Health (SAH), a company that develops therapeutic vaccines, targeting unmet needs ...

Despite the Bruhat Bengaluru Mahanagara Palike’s (BBMP) promise of regularly filling potholes, many stretches of the city’s roads remain dangerous and unmotorable, riddled with what can well ...

Ace investor Ashish Kacholia took a swipe at Bengaluru's infrastructure after the city’s notorious traffic caused him to miss a flight. Traveling from HSR Layout to Kempegowda International ...